Miyagi Cancer Center

Natori-shi 981-1293

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed